Evidence-Based Medicine Guidelines
Topiramate versus carbamazepine monotherapy for epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topiramate Versus Carbamazepine Monotherapy for Epilepsy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy.
Topiramate versus carbamazepine monotherapy for epilepsy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy. Accessed September 16, 2024.
Topiramate versus carbamazepine monotherapy for epilepsy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy
Topiramate Versus Carbamazepine Monotherapy for Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topiramate versus carbamazepine monotherapy for epilepsy
ID - 1305063
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305063/all/Topiramate_versus_carbamazepine_monotherapy_for_epilepsy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
